查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1703065

2025年心臟再同步治疗全球市场报告

Cardiac Resynchronization Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年心臟再同步治疗市场规模将强劲成长。到 2029 年，这一数字将成长至 87.7 亿美元，复合年增长率为 6.8%。预测期内的增长可归因于心臟衰竭和心臟疾病率的增加、老年人口的增加、心血管疾病发病率的增加、CRT 治疗的需求、起搏器和心臟去颤器治疗的改进以及对 CRT 治疗的认识的不断提高。预测期内的关键趋势包括采用 CRT-D 设备取代传统起搏器、整合先进技术、扩展 CRT 疗法、整合人工智慧以及采用机器学习。

心血管疾病盛行率的上升预计将推动心臟再同步治疗 (CRT) 市场的成长。心血管疾病 (CVD) 包括一系列影响心臟和血管的疾病。由于老化、不健康的生活方式、大量吸烟、久坐不动的生活方式和不良的饮食习惯等因素，心血管疾病的发生率正在增加。心臟再同步治疗透过同步电脉衝改善心臟收缩的协调性，帮助治疗心臟衰竭等疾病。例如，2024年9月，美国州卫生机构明尼苏达州卫生部的资料显示，2023年约有30%的明尼苏达州成年人报告患有高血压，影响约140万人。 2022年，高血压疾病导致该州14,225人死亡，约占所有死亡人数的28%。因此，心血管疾病盛行率的不断上升推动了心臟再同步治疗市场的需求。

医疗保健支出的增加正在推动心臟再同步治疗 (CRT) 市场的扩张。医疗保健支出是指特定时期内医疗保健商品和服务的总支出，通常是在国家或机构层面。医疗保健领域投资的增加将刺激心臟再同步治疗领域的研究和开发，从而带来技术进步、改善治疗机会以及更全面的医疗保健系统方法。例如，2023年5月，英国国家统计局报告医疗保健支出名目增加9.4%，实际成长9.7%。 2021年英国医疗保健总支出为3,672.5亿美元（2,807亿英镑），其中药品支出为518.4亿美元（396亿英镑）。 2021年预防性医疗保健支出也大幅增加，达到459.3亿美元（351亿英镑）。此外，2024年9月，美国ABA治疗服务提供商Cross River Therapy报告称，美国製药业销售额已达5,500亿美元，2021年美国在药品上的支出为5,769亿美元。预测显示，到2025年，支出将成长到6,050亿美元至6,350亿美元。因此，医疗保健支出的增加正在推动心臟再同步治疗市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球心臟再同步治疗PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球心臟再同步治疗市场：成长率分析
  • 全球心臟再同步治疗市场表现：规模与成长，2019-2024
  • 全球心臟再同步治疗市场预测：规模与成长，2024-2029，2034F
  • 全球心臟再同步治疗总目标市场（TAM）

第六章市场区隔

  • 全球心臟再同步治疗市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 心臟再同步治疗（CRT） -心臟去颤器
  • 心臟再同步治疗 (CRT) - 心律调节器
  • 全球心臟再同步治疗市场（依年龄、表现及预测）2019-2024 年、2024-2029 年、2034 年
  • 44岁以下
  • 45-64岁
  • 65-84岁
  • 85岁或以上
  • 全球心臟再同步治疗市场：依最终用途、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 心臟护理中心
  • 门诊手术中心
  • 全球心臟再同步治疗市场、心臟再同步治疗 (CRT) - 心臟去颤器细分市场、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 单腔CRT-D
  • 双腔CRT-D
  • 三腔CRT-D
  • 双心室CRT-D
  • 全球心臟再同步治疗市场、心臟再同步治疗 (CRT) - 心律调节器细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单腔CRT-P
  • 双腔CRT-P
  • 三腔CRT-P
  • 双心室CRT-P

第七章 区域和国家分析

  • 全球心臟再同步治疗市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球心臟再同步治疗市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 心臟再同步治疗市场：竞争格局
  • 心臟再同步治疗市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Lepu Medical Technology（Beijing）Co. Ltd.
  • Integer Holdings Corporation
  • Merit Medical Systems Inc.
  • LivaNova PLC
  • MicroPort Scientific Corporation
  • Sorin Group
  • Berlin Heart GmbH
  • EBR Systems Inc.
  • Corvia Medical Inc.
  • Recor Medical
  • Jarvik Heart Inc.
  • Cardiac Dimensions Inc.
  • Farapulse Inc.
  • Osypka Medical GmbH
  • Japan Medical Device Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年心臟再同步治疗市场：提供新机会的国家
  • 2029年心臟再同步治疗市场：细分市场带来新机会
  • 心臟再同步治疗市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r29723

Cardiac resynchronization therapy (CRT) is a treatment for heart failure aimed at synchronizing the contractions of the heart's ventricles. This therapy utilizes a biventricular pacemaker to administer electrical impulses to the heart muscle, thereby promoting a more coordinated rhythm of ventricular contractions. It has the potential to alleviate symptoms of heart failure, such as shortness of breath and fatigue, while also enhancing overall cardiac function.

The primary types of cardiac resynchronization therapy include cardiac resynchronization therapy (CRT)-defibrillator and cardiac resynchronization therapy (CRT)-pacemaker. A cardiac resynchronization therapy (CRT) defibrillator is a medical device designed to regulate heartbeats and deliver electrical shocks when irregular heart rhythms occur. These devices are utilized across various age groups, including patients below 44 years, 45-64 years, 65-84 years, and those aged above 85 years, by hospitals, cardiac care centers, and ambulatory surgical centers.

The cardiac resynchronization therapy market research report is one of a series of new reports from The Business Research Company that provides cardiac resynchronization therapy market statistics, including cardiac resynchronization therapy industry global market size, regional shares, competitors with a cardiac resynchronization therapy market share, detailed cardiac resynchronization therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac resynchronization therapy industry. This cardiac resynchronization therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac resynchronization therapy market size has grown strongly in recent years. It will grow from $6.29 billion in 2024 to $6.74 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growth in the geriatric population, an increased incidence of heart failure, growth in investments in R&D for CRT device innovation, increased awareness about the therapy's benefits, physician training programs, and competitive landscape dynamics.

The cardiac resynchronization therapy market size is expected to see strong growth in the next few years. It will grow to $8.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to the increasing prevalence of heart failure and cardiac disorders, growth in the geriatric population, a higher incidence of cardiovascular diseases, the need for CRT therapy, improvements in pacemakers and defibrillator treatment, and increasing awareness about CRT therapy. Major trends in the forecast period include the adoption of CRT-D devices over traditional pacemakers, the integration of advanced technology, expansion of CRT therapy, the integration of artificial intelligence, and the adoption of machine learning.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the cardiac resynchronization therapy (CRT) market. Cardiovascular diseases (CVD) encompass a range of conditions affecting the heart and blood vessels. The incidence of CVD is increasing due to factors such as aging populations, unhealthy lifestyles, high tobacco use, sedentary behavior, and poor dietary habits. Cardiac resynchronization therapy helps treat conditions like heart failure by improving the coordination of the heart's contractions through synchronized electrical impulses. For example, in September 2024, data from the Minnesota Department of Health, a US-based state health agency, revealed that approximately 30% of adults in Minnesota reported having high blood pressure in 2023, affecting nearly 1.4 million people. In 2022, hypertensive diseases were a contributing cause in 14,225 deaths in the state, accounting for almost 28% of all fatalities. As such, the growing prevalence of cardiovascular diseases is driving the demand for cardiac resynchronization therapy market.

The growing healthcare expenditure is expected to drive the expansion of the cardiac resynchronization therapy (CRT) market. Healthcare expenditure refers to the total spending on healthcare goods and services over a specific period, typically on a national or institutional level. Increased investment in healthcare can foster research and development in the field of cardiac resynchronization therapy, leading to advancements in technology, improved access to therapy, and a more comprehensive approach to healthcare systems. For example, in May 2023, the UK's Office for National Statistics reported a 9.4% nominal increase and a 9.7% practical increase in healthcare spending. In 2021, the UK's total healthcare spending was $367.25 billion (£280.7 billion), with pharmaceutical costs accounting for $51.84 billion (£39.6 billion). Spending on preventative care also surged in 2021, reaching $45.93 billion (£35.1 billion). Additionally, in September 2024, Cross River Therapy, a US-based provider of ABA therapy services, reported that the US pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicine in 2021. Projections suggest this spending will rise to $605-$635 billion by 2025. As a result, the increasing healthcare expenditure is driving the growth of the cardiac resynchronization therapy market.

Leading companies in the cardiac resynchronization therapy market are concentrating on the development of implantable devices to enhance treatment outcomes for heart failure patients. Implantable devices in CRT synchronize the contractions of the heart's ventricles, improving pumping efficiency and managing heart failure symptoms. For instance, MicroPort Scientific Corporation launched the GALI SonR cardiac resynchronization therapy and defibrillation device (CRT-D) and the Navigo 4LV left ventricular pacing leads in Japan in February 2024. This innovative CRT-D device incorporates the first and only CRT hemodynamic sensor, designed to automatically optimize patients on a weekly basis, even during physical activity, thus ensuring real-life optimization. The clinically proven SonR algorithm has demonstrated a 35% reduction in the risk of heart failure hospitalization, contributing to the well-being and safety of CRT-D patients.

Major companies operating in the cardiac resynchronization therapy market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Biotronik SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Integer Holdings Corporation, Merit Medical Systems Inc., LivaNova PLC, MicroPort Scientific Corporation, Sorin Group, Berlin Heart GmbH, EBR Systems Inc., Corvia Medical Inc., Recor Medical, Jarvik Heart Inc., Cardiac Dimensions Inc., Farapulse Inc., Osypka Medical GmbH, Japan Medical Device Corporation, Imricor Medical Systems Inc., Vascular Dynamics Inc., Svelte Medical Systems, Aleva Neurotherapeutics, BioSig Technologies Inc.

North America was the largest region in the cardiac resynchronization therapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac resynchronization therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac resynchronization therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiac resynchronization therapy market consists of revenues earned by entities by providing services such as patient evaluation and diagnosis, device implantation procedures, device programming, follow-up care, management of complications, patient education, and collaborative care involving a multidisciplinary team. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac resynchronization therapy market also includes sales of pacemakers or defibrillators, leads, programmers, accessories, diagnostic tools, patient monitoring devices, and educational materials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Resynchronization Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac resynchronization therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac resynchronization therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cardiac resynchronization therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiac Resynchronization Therapy (CRT)-Defibrillator; Cardiac Resynchronization Therapy (CRT)-Pacemaker
  • 2) By Age: Below 44 Years; 45-64 Years; 65-84 Years; Above 85 Years
  • 3) By End-Use: Hospitals; Cardiac Care Centers; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Cardiac Resynchronization Therapy (CRT)-Defibrillator: Single-Chamber CRT-D; Dual-Chamber CRT-D; Triple-Chamber CRT-D; Bi-Ventricular CRT-D
  • 2) By Cardiac Resynchronization Therapy (CRT)-Pacemaker: Single-Chamber CRT-P; Dual-Chamber CRT-P; Triple-Chamber CRT-P; Bi-Ventricular CRT-P
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; Biotronik SE & Co. KG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Resynchronization Therapy Market Characteristics

3. Cardiac Resynchronization Therapy Market Trends And Strategies

4. Cardiac Resynchronization Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cardiac Resynchronization Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac Resynchronization Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac Resynchronization Therapy Market Growth Rate Analysis
  • 5.4. Global Cardiac Resynchronization Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac Resynchronization Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac Resynchronization Therapy Total Addressable Market (TAM)

6. Cardiac Resynchronization Therapy Market Segmentation

  • 6.1. Global Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Resynchronization Therapy (CRT)-Defibrillator
  • Cardiac Resynchronization Therapy (CRT)-Pacemaker
  • 6.2. Global Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Below 44 Years
  • 45-64 Years
  • 65-84 Years
  • Above 85 Years
  • 6.3. Global Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiac Care Centers
  • Ambulatory Surgical Centers
  • 6.4. Global Cardiac Resynchronization Therapy Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT)-Defibrillator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber CRT-D
  • Dual-Chamber CRT-D
  • Triple-Chamber CRT-D
  • Bi-Ventricular CRT-D
  • 6.5. Global Cardiac Resynchronization Therapy Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT)-Pacemaker, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber CRT-P
  • Dual-Chamber CRT-P
  • Triple-Chamber CRT-P
  • Bi-Ventricular CRT-P

7. Cardiac Resynchronization Therapy Market Regional And Country Analysis

  • 7.1. Global Cardiac Resynchronization Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac Resynchronization Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Resynchronization Therapy Market

  • 8.1. Asia-Pacific Cardiac Resynchronization Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Resynchronization Therapy Market

  • 9.1. China Cardiac Resynchronization Therapy Market Overview
  • 9.2. China Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Resynchronization Therapy Market

  • 10.1. India Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Resynchronization Therapy Market

  • 11.1. Japan Cardiac Resynchronization Therapy Market Overview
  • 11.2. Japan Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Resynchronization Therapy Market

  • 12.1. Australia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Resynchronization Therapy Market

  • 13.1. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Resynchronization Therapy Market

  • 14.1. South Korea Cardiac Resynchronization Therapy Market Overview
  • 14.2. South Korea Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Resynchronization Therapy Market

  • 15.1. Western Europe Cardiac Resynchronization Therapy Market Overview
  • 15.2. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Resynchronization Therapy Market

  • 16.1. UK Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Resynchronization Therapy Market

  • 17.1. Germany Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Resynchronization Therapy Market

  • 18.1. France Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Resynchronization Therapy Market

  • 19.1. Italy Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Resynchronization Therapy Market

  • 20.1. Spain Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Resynchronization Therapy Market

  • 21.1. Eastern Europe Cardiac Resynchronization Therapy Market Overview
  • 21.2. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Resynchronization Therapy Market

  • 22.1. Russia Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Resynchronization Therapy Market

  • 23.1. North America Cardiac Resynchronization Therapy Market Overview
  • 23.2. North America Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Resynchronization Therapy Market

  • 24.1. USA Cardiac Resynchronization Therapy Market Overview
  • 24.2. USA Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Resynchronization Therapy Market

  • 25.1. Canada Cardiac Resynchronization Therapy Market Overview
  • 25.2. Canada Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Resynchronization Therapy Market

  • 26.1. South America Cardiac Resynchronization Therapy Market Overview
  • 26.2. South America Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Resynchronization Therapy Market

  • 27.1. Brazil Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Resynchronization Therapy Market

  • 28.1. Middle East Cardiac Resynchronization Therapy Market Overview
  • 28.2. Middle East Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Resynchronization Therapy Market

  • 29.1. Africa Cardiac Resynchronization Therapy Market Overview
  • 29.2. Africa Cardiac Resynchronization Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac Resynchronization Therapy Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac Resynchronization Therapy Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Resynchronization Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Resynchronization Therapy Market Competitive Landscape
  • 30.2. Cardiac Resynchronization Therapy Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Resynchronization Therapy Market Other Major And Innovative Companies

  • 31.1. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.2. Integer Holdings Corporation
  • 31.3. Merit Medical Systems Inc.
  • 31.4. LivaNova PLC
  • 31.5. MicroPort Scientific Corporation
  • 31.6. Sorin Group
  • 31.7. Berlin Heart GmbH
  • 31.8. EBR Systems Inc.
  • 31.9. Corvia Medical Inc.
  • 31.10. Recor Medical
  • 31.11. Jarvik Heart Inc.
  • 31.12. Cardiac Dimensions Inc.
  • 31.13. Farapulse Inc.
  • 31.14. Osypka Medical GmbH
  • 31.15. Japan Medical Device Corporation

32. Global Cardiac Resynchronization Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Resynchronization Therapy Market

34. Recent Developments In The Cardiac Resynchronization Therapy Market

35. Cardiac Resynchronization Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac Resynchronization Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Resynchronization Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Resynchronization Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer